Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 25, 2025Frontiers in ImmunologyOpen Access

Rapid early remission in a patient with severe aplastic anemia: a case report of hetrombopag, cyclosporine, and danazol combination therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

YDYuting DaiQGQiang GuoXGXiaoxiao Guo

Discussion

Loading...

Member takes

Overview

Case report shows complete response in severe aplastic anemia with hetrombopag and cyclosporine, suggesting alternative treatment paths.

Key Points

  • Complete response observed at 6 months in a patient with severe aplastic anemia after therapy with hetrombopag, cyclosporine, and danazol.
  • Key hematologic assessments indicated a partial response at 3 months, supporting the effectiveness of this treatment regimen for severe aplastic anemia.
  • Combination intervention started with hetrombopag, cyclosporine, and danazol, suggesting a promising alternative to traditional immunosuppressive therapies.
  • No severe adverse events occurred during treatment, highlighting potential safety alongside efficacy requiring further large-scale validation.

Cite This Study

Dai et al. (2025) studied this question.

synapsesocial.com/papers/68af7b1f7567bf4f94ff2dddhttps://doi.org/10.3389/fimmu.2025.1609771
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rapid initiation of cyclosporine and eltrombopag ahead of definitive treatment decreases autoimmunity and expedites marrow recovery in a prospective phase II trial2025 · 1 citations
  2. 2Hetrombopag Added to Cyclosporine as the First‐Line Treatment for Patients With Non‐Severe Aplastic Anemia: A Phase 2 Multicenter Trial2026
  3. 3[A new era in the treatment of aplastic anemia].2025
  4. 4Case report: Spontaneous remission of severe aplastic anemia mediated by mutant hematopoietic stem cells evading T-cell attack2025
  5. 5A novel reduced-toxicity conditioning regimen with busulfan/fludarabine/cyclophosphamide/anti-thymocyte globulin for severe aplastic anemia2025